Adherence to the new British Society for Rheumatology Psoriatic Arthritis guidelines for anti-tumour necrosis factor therapy

被引：0
|
作者：
Farquhar, K.
Reid, M.
Hanlon, S.
Perry, M. E.
机构：
[1] Royal Alexandra Hosp, Dept Rheumatol, Edmonton, AB, Canada
[2] Inverclyde Royal Hosp, Dept Rheumatol, Greenock, Scotland
来源：
SCOTTISH MEDICAL JOURNAL | 2015年 / 60卷 / 03期
关键词：
Psoriatic arthritis; biologic therapy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E14 / E15
页数：2
相关论文
共 50 条
  • [21] DOES DEPRESSION AFFECT RESPONSE TO ANTI-TUMOUR NECROSIS FACTOR-α THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)? RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER (BSRBR)
    Davies, R.
    Mercer, L. K.
    Galloway, J. B.
    Low, A. S.
    Watson, K. D.
    Lunt, M.
    Symmons, D. P.
    Hyrich, K. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 521 - 522
  • [22] Eliciting Prescribing Choices of Anti-Tumour Necrosis Factor Therapy From Rheumatology Trainees
    Hughes, Rodney A.
    Carr, Alison J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S803 - S804
  • [23] The Risk of Solid Cancer in Patients Receiving Anti-Tumour Necrosis Factor Therapy for Rheumatoid Arthritis for up to 5 Years: Results From the British Society for Rheumatology Biologics Register
    Mercer, Louise K.
    Galloway, James B.
    Low, Audrey S. L.
    Watson, Kath D.
    Lunt, Mark
    Dixon, William G.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S988 - S989
  • [24] Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines
    Kassimos, DG
    Garyfallos, A
    Delamere, J
    Whallett, A
    Kitas, GD
    RHEUMATOLOGY, 2003, 42 (03) : 490 - 490
  • [25] Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Madhok, Rajan
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1571 - 1571
  • [26] Salmonella enterica Arthritis in a Patient with Rheumatoid Arthritis Receiving Anti-tumour Necrosis Factor Therapy
    Bubonja-Sonje, M.
    Rubinic, D.
    Anic, F.
    Novak, S.
    Vuckovic, D.
    Abram, M.
    WEST INDIAN MEDICAL JOURNAL, 2013, 62 (03): : 270 - 272
  • [27] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    Arthritis Research & Therapy, 4 (1)
  • [28] Anti-tumour necrosis factor therapy in the West Midlands
    Bartram, D
    Sheeran, T
    Price, T
    Mulherin, D
    RHEUMATOLOGY, 2004, 43 (03) : 400 - 400
  • [29] Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
    Swales, C
    Bowness, P
    CLINICAL MEDICINE, 2005, 5 (03) : 219 - 222
  • [30] Incidence of Congestive Heart Failure in Subjects with Rheumatoid Arthritis Receiving Anti-Tumour Necrosis Factor Drugs: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    van Sijl, Alper
    Mamas, Mamas
    Lunt, Mark
    Watson, Kath
    Symmons, Deborah P.
    Hyrich, Kimme L.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S840 - S840
12345